Immunoprecipitation to Determine JAK Kinase Activation in Response to Interleukins in Ovarian Cancer
In cytokine receptors, there is no consensus sequence motif for tyrosine and/or serine/threonine kinases in its intracellular domain (1 ). Cytokine receptors associate with and activate members of the Janus kinase family (JAK), which is phosphorylated following ligand binding (2 ). The JAK family consists of four kinase members, JAK1, JAK2, JAK3, and Tyk2. Recently, we have shown that in ovarian cancer cell lines, many IL-4 receptors were expressed and IL-4 inhibited the proliferation of ovarian carcinoma cell lines (3 ). Moreover, IL-4 induced the phosphorylation of JAK1, JAK2, Tyk2, STAT6, and IRS-1 proteins following ligand-receptor interaction (4 ).
- Generation of Recombinant Immunotoxins for Specific Targeting of Tumor-Related Peptides Presented by MHC Molecules
- cDNA Microarray Analysis of Inflammatory Breast Cancer Signatures
- Use of DNA Fingerprinting to Detect Genetic Rearrangements in Human Cancer
- High-Throughput Mutation Screening Using a Single Amplification Condition
- Clinical Implications of Epigenetic Alterations in Human Thoracic Malignancies: Epigenetic Alterations in Lung Cancer
- The APC Tumor Suppressor Pathway
- Identification of Steroid Hormone-Regulated Genes in Breast Cancer
- Growth of Prostatic Epithelial and Stromal Cells In Vitro
- Evaluating Response to Antineoplastic Drug Combinations in Tissue Culture Models
- Transgenic Animal Models